Trial Profile
A Double-Blind, Placebo-Controlled Study of Vortioxetine in the Treatment of Binge Eating Disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 May 2020
Price :
$35
*
At a glance
- Drugs Vortioxetine (Primary)
- Indications Binge-eating disorder
- Focus Therapeutic Use
- 03 Dec 2018 Status changed from recruiting to completed.
- 16 Jun 2016 Planned End Date changed from 1 Oct 2017 to 1 Oct 2018.
- 16 Jun 2016 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2018.